Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 28, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

What is the patent landscape for Prednisolone, and what generic Prednisolone alternatives are available?

Prednisolone is a drug marketed by Hi Tech Pharma Co, Marshall Pharma, Pvt Form, Wockhardt, Watson Labs, Teva Pharms, Phoenix Labs Ny, Nesher Pharms, Vistapharm, West Ward, Elkins Sinn, Purepac Pharm, Barr, Heather, Roxane, Lannett, Vitarine, Valeant Pharm Intl, Everylife, Sandoz, Chartwell Rx, Whiteworth Town Plsn, Inwood Labs, Panray, Sperti, Ferrante, Apotex Inc, Tablicaps, Aurolife Pharma Llc, Vintage, Bundy, Ivax Sub Teva Pharms, Impax Labs, UDL, We Pharms, Superpharm, Teva, Pharm Assoc, Cent Pharms, Akorn, Bel Mar, Vintage Pharms, Alcon Pharms Ltd, Amneal Pharms, Medicis Pharms, Edenbridge Pharms, Bausch And Lomb, Sola Barnes Hind, Mylan Pharms Inc, Hi Tech Pharma, Paddock Llc, and Mission Pharma. and is included in eighty-two NDAs.

The generic ingredient in PREDNISOLONE is prednisolone tebutate. There are eighty-five drug master file entries for this compound. Additional details are available on the prednisolone tebutate profile page.

Summary for Tradename: PREDNISOLONE

Suppliers / Packagers: see list16
Bulk Api Vendors: see list51
Clinical Trials: see list149
Patent Applications: see list6,916
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PREDNISOLONE at DailyMed

Pharmacology for Tradename: PREDNISOLONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
prednisolone sodium phosphate
SOLUTION/DROPS;OPHTHALMIC083358-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
TABLET;ORAL083675-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
TABLET;ORAL080358-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Nesher Pharms
prednisolone sodium phosphate
SOLUTION;ORAL076982-001May 24, 2005DISCNNoNo► Subscribe► Subscribe
TABLET;ORAL080398-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus